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ABSTRACT 
 
 
 
 
 
Nupr1 is a protein initially identified as a cancer cell marker, though its role in cancer cell 
metastasis and tumorigenesis is currently ambiguous. Here we identify Nupr1 as a 
mechanosensitive protein involved in the regulation of tumor cell plasticity and Sox2 expression. 
We monitored Nupr1 and Sox2 expression over time in cells cultured in soft 3D fibrin matrices. 
Using both untreated and Nupr1-siRNA treated cells, we find that high Nupr1 expression 
prevents increase in Sox2 levels. Further, we find that Nupr1 expression is sensitive to substrate 
stiffness and dependent on ligand type, as Nupr1 expression increased with substrate stiffness on 
polyacrylamide substrates coated with col-1 but not fibrinogen. Finally, we find that Nupr1 is 
sensitive to stiffness in 3D culture as well, and is downstream of Cdc42-mediated cytoskeletal 
softening. Together, our data shows that Nupr1 responds to the physical properties of its 
surroundings and can regulate tumor cell plasticity via delay of Sox2 expression in 3D.
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CHAPTER 1 || GENERAL INTRODUCTION 
 
 
 
The process by which cells integrate mechanical signals and forces into biochemical changes, 
including processes such as gene upregulation, protein assembly, and transport of molecules, 
is known as mechanotransduction. Though soluble factors and molecular signaling have long 
been studied for their effects on cell behavior, much more emphasis is now being placed on a 
cell’s mechanical microenvironment, cytoskeleton, and the cell’s response to individual 
mechanical forces. Indeed, mechanics have been shown to play a large role in many cellular 
functions and behaviors
1,2,3,4
. In particular, cell plasticity has been shown to respond to the 
physical properties of the cell’s surroundings and exogenous forces5,6,7,8.  
 
During development of an organism, the fertilized zygote is a totipotent stem cell: that is, it 
can give rise to every single cell necessary for the development of the organism. As time goes 
on such stem cells, which also display self-renewing characteristics, divide into more 
specified lineages, from which they can give rise to fully differentiated cells of a specific 
type. This ability to self-renew and change cell type is referred to as plasticity. Beyond 
development, cell plasticity is also important through the adult life of an organism, as adult 
stem cells continually give rise to new cells within the body whenever necessary. The 
division, differentiation, and spatial organization/integration of such cells requires 
coordination of multiple signals and numerous changes in gene expression, though exactly 
how this occurs remains largely elusive. 
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Tissue engineering has long sought after the ability to control differentiation and growth of 
plastic cells into functional tissues and organs of choice. This ability remains unachieved, yet 
multiple regulating factors of plasticity have been identified and studied: particularly, the 
mechanical properties of the cell and its surroundings have emerged as important factors in 
cell fate decisions. Surface topography, substrate stiffness, and exogenous forces applied to 
the cell are all external factors shown to greatly affect differentiation and self-renewal; colony 
size, cell geometry, and cell softness are intrinsic factors which play similarly important roles 
as well
12
. 
 
Plasticity in Cancer 
Though once thought to be an agglomeration of genetically mutated but identical cells, the 
tumor is now better understood as a heterogeneous, somewhat dysregulated growth of 
cancerous cells. The ability of a small fraction of these cancer cells to escape the primary 
tumor, survive in the bloodstream, and generate tumors in distant organs gave rise to the idea 
of cancer stem cells (CSCs)
13,14,15
. This idea initially received traction with identification of 
CSC markers, but isolating these rare cells has made their study difficult, and among those 
that have studied CSCs exists significant disagreement, leaving a cloud of ambiguity 
surrounding their relevance
10,11
; even among cancer cells displaying tumorigenicity and self-
renewal, the expression of CSC markers is not consistent
16
. 
 
Previously, our lab has seen that substrate softness can regulate self-renewal and 
differentiation in mouse embryonic stem cells (ESCs) independent of soluble factors, such as 
Leukemia Inhibitory Factor (LIF)
7
. Softer substrates were shown to maintain self-renewal of 
ESCs, while stiffer substrates caused ESCs to differentiate
17
. Hypothesizing that the 
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mechanical properties of a cancer cells surroundings may be able to affect their plastic state, 
we cultured B16 mouse melanoma cells in soft 3D fibrin gels of 90 Pa stiffness for 5 days*
1
. 
Hypothesizing that the soft matrix culture may have acquired tumorigenic properties, they 
were injected subcutaneously into mice. Remarkably, compared to B16 cells grown on rigid 
plastic dishes, these soft-matrix cultured cells were up to a thousand times more likely to 
form metastatic tumors in the mouse lung
18
. These cells, dubbed tumor repopulating cells 
(TRCs), also exhibit high levels of stem cell genes including Sox2. 
 
Mechanisms regulating plasticity in TRCs 
Our most recent work has elucidated the mechanisms involved in regulation of TRC 
plasticity. Since TRCs exhibit changes in mechanical properties and stem cell gene 
expression (i.e. Sox2), the study focused on the relationship among cell softening, epigenetic 
modifications, and gene expression.  
 
Of the numerous epigenetic mechanisms, modification of lysine tails on histone proteins is 
one of the foremost ways by which the cell can turn certain genes on or off. Using a FRET 
biosensor to monitor histone-3-lysine-9 (H3K9) di- and trimethylation (me2 and me3), we 
found that TRCs, unlike B16 cells grown on plastic, did not increase H3K9me when 
subjected to exogenous forces. The cytoskeletal softening of TRCs, which we subsequently 
found to be mediated by Cdc42 expression, prevented transfer of mechanical signals to the 
nucleus. Importantly, H3K9me was inversely correlated with Sox2 expression. Taken 
                                                          
* Recent work has shown that while the outer periphery of the primary tumor is stiffer due to presence of 
extra stroma and matrix proteins, the center of the tumor remains much softer. Additionally, the stiffness of 
metastatic colonies in a mouse lung matches the softness of the inner core of the primary tumor [18] 
4 
together, we showed that Cdc42-mediated softening of TRCs caused H3K9 demethylation, 
leading to increased Sox2 levels and TRC self-renewal
19
.  
 
Nupr1 as a mechanosensitive gene 
The presented work is aimed at understanding the role and mechanosensitivity of Nupr1. 
There is much speculation and evidence for the ability of mechanical forces at the cell surface 
to directly cause changes in gene expression
20
. Work has been done using artificially inserted 
genes, but there is need for the study of functional mechanosensitive genes. 
 
This work shows Nupr1 to be a mechanosensitive protein important in the regulation of 
tumor cell plasticity. 
 
  
5 
CHAPTER 2 || NUPR1 AS A MECHANOSENSITIVE REGULATOR OF TUMOR CELL 
PLASTICITY 
 
2.1 Introduction  
Previous work has in general shown the importance of mechanics in plasticity, both in 
developmental and cancerous cells. There are multiple proteins and structures directly linking 
the nuclear membrane and periphery to the cell member, allowing transmission of force 
directly to genetic information. However, current studies of such events are limited by 
insertion of foreign genetic material. To study the effects of force-induced chromatin 
stretching and gene expression in live cells, it is prudent to examine a functional gene of 
interest. In this chapter we explore nuclear protein 1 (Nupr1) as a candidate for such a study, 
due to its apparent role in tumorigenecity of cancer cells. 
 
2.2 Motivation 
Nupr1 is a DNA-binding protein implicated in regulation of the cell cycle and apoptosis
21
. It 
was first identified as COM1 (candidate of metastasis 1) due to its discovery as a highly 
upregulated marker of metastatic cancer cells
22
. Since its first identification, however, not 
much is understood of its functions in either normal or cancerous cells. Several studies have 
identified expression of Nupr1 as an important player in various types of cancer cells’ ability 
to survive 
23,24,25,26
, while others have highlighted its tumor-suppressing characteristics
27
. 
 
Previously, we developed a method for selecting a highly tumorigenic subpopulation of 
cancer cells by culturing them in soft, 90 Pa 3D fibrin matrices. This gives us an interesting 
platform to compare the activity of Nupr1 in tumorigenic vs more benign cancer cells, 
elucidating previously unknown pathways regulating cancer cell metastasis and survival. 
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To further determine whether Nupr1 will be a proper candidate for studying chromatin-
stretch induced gene expression, we must first understand the response of Nupr1 to 
mechanical perturbation.  The proceeding sections aim to understand its mechanosensitive 
behaviors. 
 
2.3 Results 
2.3.1 Nupr1 delays Sox2 expression 
Sox2 has previously been shown to be crucial to the self-renewing characteristics of TRCs
28
, 
so first we examined the relationship between Nupr1 and Sox2 by looking at their expression 
over time.  Untreated B16 mouse melanoma cells were cultured on plastic, then transferred to 
3D fibrin matrices of 90 Pa stiffness for up to 5 days, with cells extracted after 1, 2, 3, and 5 
days of 3D culture. RT-qPCR was used to monitor Nupr1 and Sox2 expression levels. In 
untreated cells, Sox2 expression was found to increase after 3 days of 3D fibrin culture; 
interestingly, Nupr1 levels decreased by day 2 of 3D culture, just before Sox2 increase (Fig. 
1). Seeing this behavior, we hypothesized that high Nupr1 levels may prevent Sox2 
expression. 
 
To test the dependence of Sox2 expression on Nupr1, we repeated the above procedure with 
cells treated with Nupr1 siRNA (knockdown efficiency >90%, see Fig. 1b). Simply knocking 
down Nupr1 did not increase Sox2 expression in cells cultured on rigid plastic. However, 
when siRNA treated cells were transferred to 3D, Sox2 expression increased ~600% within 1 
day (opposed to 3 days in untreated cells). It seems that low Nupr1 expression allows Sox2 
levels to increase in soft 3D fibrin culture. Our data shows, however, that low Nupr1 is not 
7 
sufficient for Sox2 increase, due to lack of Sox2 expression in siRNA treated cells grown on 
rigid plastic. Taken together, Nupr1 appears to delay the expression of Sox2. 
 
2.3.2 Nupr1 displays ligand dependence in response to substrate properties 
In 90Pa fibrin culture, cells knockdown Nupr1 levels by ~90% (Fig. 1B). Since culturing 
cells in 90Pa fibrin requires a transfer of cells from a stiff, rigid plastic dish into a softer 
mechanical environment, we hypothesized that Nupr1 levels may respond to substrate 
stiffness. To test this hypothesis we transferred cells to 2D polyacrylamide (PA) substrates of 
0.15, 2, or 8 kPa stiffness for 3 hours. Additionally, we wanted to test whether any observed 
mechanosensitivity of Nupr1 was due specifically to the ligands which the cell senses in its 
mechanical environment. The cell accomplishes this through surface receptors called 
integrins which display specificity of binding with various ECM ligands. To test ligand 
dependence, we coated the PA substrates with either collagen-1 (200 µg/ml) or fibrinogen 
(100 µg/ml) ECM proteins. Afterwards RT-qPCR was used to monitor changes in Nupr1 
expression. When plated on fibrinogen coated PA substrates, the cells did not change their 
Nupr1 expression (p > 0.50) (Fig. 2A). On collagen-1 coated PA gels, however, Nupr1 
expression increased with substrate stiffness (Fig. 2B). Going from 0.15 and 2 kPa stiffness 
gels, Nupr1 levels increased by ~10%, and between 2 and 8 kPa by ~20%.  
 
As the previous set of experiments were carried out in 2D, we wanted to further explore 
Nupr1’s mechanosensitivity by perturbing stiffness in a 3D environment. To do this we 
compared expression levels between cells cultured in 90 or 1050 Pa stiffness 3D fibrin 
matrices. After 5 days culture time in 3D, cells from the 1050 Pa fibrin matrices displayed 
~25% higher Nupr1 levels compared to those from 90 Pa (Fig. 3).   
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2.3.3 Nupr1 is downstream of Cdc42-mediated cell softening 
Since Cdc42 was previously shown to mediate cytoskeletal stiffness, and thus eventually 
Sox2 expression, we wanted to see whether it also affects Nupr1 expression levels. We have 
already seen that softer substrates, which lead to lower endogenous forces from the cell, lead 
to lower Nupr1 expression. So, we hypothesized that knocking down Cdc42, which will lead 
to cytoskeletal softening, should also decrease Nupr1 expression. Indeed, culturing cells on 
rigid plastic and treating with Cdc42 siRNA (48hr incubation time) led to ~70% decrease in 
Nupr1 levels (Fig. 4), confirming that Nupr1 expression is downstream of cytoskeletal 
softening. 
 
 
2.4 Conclusion 
Nupr1 is an intriguing protein due to both its implication in cancer survival and its physical 
association with DNA. Not much is understood regarding how Nupr1 functions in cancer.  
Here we show that Nupr1 expression is correlated positively with cytoskeletal tension, 
displaying ligand dependent sensitivity to substrate stiffness. Further, expression of Nupr1 
delays the expression of Sox2 in 3D soft fibrin matrices, affecting cell tumorigenicity.  
 
It appears that Nupr1 is most likely an intermediate between cytoskeletal softening and Sox2 
upregulation. There has been recent evidence for binding activity between MSL1 and Nupr1 
proteins in Drosophila, which together may be regulating histone acetyltransferase activity. It 
9 
would be interesting to see if other epigenetic changes are occurring due to Nupr1 activity, 
and if the Nupr1 gene is directly regulated by mechanical force.   
10 
 
 
 
 
 
 
 
 
 
 
 
FIGURES 
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Figure 1. Nupr1 delays expression of Sox2 in TRCs.  Cells were first cultured on plastic, then 
transferred to 3D fibrin culture (90Pa stiffness) for multiple days.  Cells were extracted at 1, 2, 3, and 
5 days.  Expression of (a) Nupr1 and (b) Sox2 were evaluated using RT-qPCR. Mean±s.e.m. n=3 
independent experiments. In untreated cells, Nupr1 levels decrease after 2 days of 3D fibrin culture, 
allowing Sox2 levels to increase soon after on day 3. In +Nupr1 siRNA treated cells Nupr1 levels are 
low, allowing Sox2 levels to increase after just 1 day of 3D fibrin culture. *(p<0.05) 
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Figure 2. Nupr1 expression increases with substrate stiffness on 2D col-1 but not fibrinogen. 
Cells were plated on 2D polyacrylamide (PA) substrates for 3hr. Control cells were cultured on 0.1% 
gelatin coated rigid plastic dishes. PA substrates were coated with either (a) fibrinogen (100 µg/ml) 
or (b) col-1 (200 µg/ml). Gene expression change was monitored using RT-qPCR, with n=3 
independent experiments. Cells plated on 2D fibrinogen displayed no changes in Nupr1 levels with 
changing substrate stiffness. However, cells plated on 2D col-1 increased Nupr1 levels with 
increasing substrate stiffness. (Mean±s.e.m.) *(p<0.05) 
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Figure 3. Nupr1 levels increase with increasing matrix stiffness in 3D.  Cells were cultured in 3D 
fibrin matrices of either 90 or 1050 Pa stiffness for 5 days.  Nupr1 expression was monitored using 
RT-qPCR with n=3 independent experiments. Increasing matrix stiffness from 90 to 1050 Pa 
increased Nupr1 expression by ~25%. (Mean±s.e.m.) *(p<0.05) 
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Figure 4. Cdc42 is an upstream effector of Nupr1.  Cells were treated with Cdc42 siRNA for 48 
hours on rigid plastic dish. Nupr1 expression was quantified using RT-qPCR (Mean ± s.e.m.) with 
n=3 independent experiments. Knockdown of Cdc42 resulted in ~70% decrease in Nupr1 expression. 
*(p<0.05) 
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